— Know what they know.
Not Investment Advice

XCUR NASDAQ

Exicure, Inc.
1W: -5.7% 1M: -10.8% 3M: -42.2% YTD: -79.4% 1Y: -72.0% 3Y: -67.6% 5Y: -99.4%
$1.15
-0.03 (-2.54%)
 
Weekly Expected Move ±10.5%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 26 · $7.3M mcap · 2M float · 22.46% daily turnover · Short 44% of daily vol

Balance Sheet Trends

Total Assets
$14M -6.7% ▼
5Y CAGR: -32.5%
Total Liabilities
$10M +22.1% ▲
5Y CAGR: -23.6%
Shareholders Equity
$4M -42.0% ▼
5Y CAGR: -42.3%
Cash & Investments
$4M -70.1% ▼
5Y CAGR: -46.1%
Total Debt
$176K -97.0% ▼
5Y CAGR: -62.8%
Net Debt
-$4M +45.7% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$35M$9M$816K$13M$4M
Short-Term Investments$4M$0$0$0$0
Cash & ST Investments$39M$9M$816K$13M$4M
Net Receivables$0$0$250K$521K$58K
Inventory$0$0$0$0$0
Other Current Assets$1M$853K$24K$69K$820K
Total Current Assets$44M$10M$2M$14M$5M
Property, Plant & Equip.$12M$10M$7M$26K$306K
Goodwill & Intangibles$0$0$0$0$8M
Long-Term Investments$0$1M$1M$0$0
Other Non-Current Assets$9M$2M$2M$1M$928K
Total Non-Current Assets$21M$13M$10M$1M$9M
Total Assets$65M$23M$12M$15M$14M
— Liabilities —
Accounts Payable$3M$361K$2M$1M$2M
Short-Term Debt$7M$539K$0$0$176K
Deferred Revenue$17M$0$0$0$0
Other Current Liabilities$0$707K$0$0$2M
Total Current Liabilities$34M$2M$3M$3M$4M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$656K$0$0$0$6M
Total Non-Current Liabilities$20M$7M$6M$5M$6M
Total Liabilities$54M$8M$9M$8M$10M
— Equity —
Common Stock$11K$0$0$1K$1K
Retained Earnings-$170M-$173M-$190M-$199M-$204M
Accumulated OCI-$2K$0$0$0-$2K
Total Stockholders Equity$11M$15M$3M$7M$4M
Total Liabilities & Equity$65M$23M$12M$15M$14M
— Key Metrics —
Total Debt$15M$7M$7M$6M$176K
Net Debt-$20M-$1M$6M-$7M-$4M
Total Investments$4M$1M$1M$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms